You have 2 free disease views remaining today. Register for more view, it is 100% free →
Cowden syndrome 7
ICD-10 Codes
Related ICD-10:
Description
Cowden Syndrome 7 (CWS7) Description
Cowden syndrome 7, also known as CWS7, is a rare genetic disorder characterized by the presence of multiple hamartomas in various tissues and an increased risk for malignancies.
- Caused by SEC23B gene mutation: CWS7 is caused by heterozygous mutations in the SEC23B gene on chromosome 20p11 [5].
- Hamartomatous lesions: The condition is characterized by the presence of hamartomatous lesions, which are noncancerous growths that can occur in various parts of the body.
- Increased risk for malignancies: Individuals with CWS7 have an increased risk for developing certain types of cancer, including breast, thyroid, and endometrial cancers [5].
- Genetic heterogeneity: Cowden syndrome 7 is part of a group of diseases known as PTEN-related diseases, which also includes Lhermitte-Duclos disease [14].
References:
[5] - CWS7 is caused by heterozygous mutation in the SEC23B gene (610512) on chromosome 20p11. [14] - Cowden syndrome is part of a group of disease known as PTEN-related diseases, which also includes Lhermitte-Duclos disease.
Additional Characteristics
- Cowden syndrome 7, also known as CWS7, is a rare genetic disorder characterized by the presence of multiple hamartomas in various tissues and an increased risk for malignancies.
- The condition is characterized by the presence of hamartomatous lesions, which are noncancerous growths that can occur in various parts of the body.
- Individuals with CWS7 have an increased risk for developing certain types of cancer, including breast, thyroid, and endometrial cancers.
- Cowden syndrome 7 is part of a group of diseases known as PTEN-related diseases, which also includes Lhermitte-Duclos disease.
Signs and Symptoms
Common Characteristics of Cowden Syndrome
Cowden syndrome, also known as multiple hamartoma syndrome, is a rare genetic disorder that affects various parts of the body. The common characteristics of this condition include:
- Breast problems (females): Fibroadenomas, fibrocystic disease, and other breast-related issues are prevalent in females with Cowden syndrome [7].
- Gastrointestinal: Hamartomatous polyps and other gastrointestinal issues can occur in individuals with Cowden syndrome [7].
- Other potential symptoms: While not exhaustive, these common characteristics provide a starting point for understanding the signs and symptoms of Cowden syndrome.
Additional Signs and Symptoms
In addition to the above-mentioned characteristics, people with Cowden syndrome may also experience:
- Macrocephaly (a larger-than-average head size)
- Trichilemmomas (benign hair follicle tumors)
- Papillomatous papules
- Rare, noncancerous brain tumor called Lhermitte-Duclos disease
These symptoms can vary in severity and may not be present in every individual with Cowden syndrome.
References:
[7] Apr 1, 2021 - Common characteristics of Cowden syndrome; Breast problems (females), Fibroadenomas, fibrocystic disease, 40% ; Gastrointestinal, Hamartomatous polyps and other gastrointestinal issues can occur in individuals with Cowden syndrome.
Additional Symptoms
- Macrocephaly
- Trichilemmomas
- Papillomatous papules
- Breast problems (females)
- Fibroadenomas
- Fibrocystic disease
- Gastrointestinal
- Hamartomatous polyps
- Lhermitte-Duclos disease
Diagnostic Tests
Cowden syndrome, also known as PTEN hamartoma tumor syndrome (PHTS), is a rare genetic disorder that can be challenging to diagnose. Diagnostic tests for Cowden syndrome are crucial in confirming the presence of this condition.
Major and Minor Diagnostic Criteria
According to search result [3], an operational diagnosis is given if a patient displays the pathognomonic skin lesions, two or more major, one major and 3 or more minor, or 4 or more minor diagnostic criteria. These criteria are essential in diagnosing Cowden syndrome.
PTEN Genetic Testing
Search result [4] states that PTEN genetic testing may be considered medically necessary when a presumptive diagnosis of a PTEN hamartoma tumor syndrome has been made. This test is crucial in confirming the presence of the PTEN gene mutation associated with Cowden syndrome.
Cancer Screening Tests
According to search result [5], people are diagnosed with Cowden syndrome based mainly on sets of major and minor diagnostic criteria, including cancer screening tests. These tests include:
- Annual mammography and breast MRI screening starting at age 30-35 years or 5-10 years prior to earliest breast cancer diagnosis (search result [6])
- Other cancer screening tests may also be recommended
Diagnostic Flowchart
Search result [2] provides a diagnostic flowchart for Cowden syndrome/PHTS, including PTEN testing criteria. This flowchart can help guide healthcare professionals in diagnosing this condition.
In summary, the diagnostic tests for Cowden syndrome include:
- Major and minor diagnostic criteria
- PTEN genetic testing
- Cancer screening tests (such as annual mammography and breast MRI)
- Diagnostic flowcharts to guide diagnosis
These tests are essential in confirming the presence of Cowden syndrome and guiding treatment decisions.
Additional Diagnostic Tests
- Major and Minor Diagnostic Criteria
- PTEN Genetic Testing
- Cancer Screening Tests
- Diagnostic Flowchart
Treatment
Treatment Options for Cowden Syndrome
Cowden syndrome, also known as multiple hamartoma syndrome, is a rare genetic disorder characterized by the growth of numerous benign tumors in various parts of the body. While there is no cure for Cowden syndrome, several treatment options are available to manage its symptoms and prevent complications.
- Rapamycin (Sirolimus): This mTOR inhibitor has shown promising outcomes in clinical trials for treating cancer in people with PTEN mutations, which are often associated with Cowden syndrome. Rapamycin can help reverse the skin manifestations of Cowden syndrome and modulate the mTOR pathway [7].
- AKT Inhibitors: These inhibitors may be effective for treating cancer in people with PTEN mutations, including those with Cowden syndrome [4].
It's essential to note that treatment options for Cowden syndrome are still evolving, and more research is needed to fully understand its effects. If you're considering treatment for Cowden syndrome, consult with a qualified healthcare professional to discuss the best course of action.
References: [7] Aug 28, 2008 — Rapamycin treatment reverses Cowden's disease–like lesions and modulates mTOR pathway in K14Cre PtenF/F–derived tumors. A, representative ... [4] Sep 1, 2024 — AKT inhibitors may be effective for treating cancer in people with PTEN mutations. Metastatic or advanced HR-positive breast cancer. Truqap ...
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
Differential Diagnosis of Cowden Syndrome
Cowden syndrome, also known as PTEN hamartoma tumor syndrome, is a rare genetic disorder characterized by multiple hamartomas and an increased risk of certain cancers. When considering the differential diagnosis for Cowden syndrome, several conditions should be taken into account.
- Birt-Hogg-Dube syndrome: This is another rare genetic disorder that affects the skin, lungs, and kidneys. Like Cowden syndrome, it is characterized by multiple hamartomas and an increased risk of certain cancers [1].
- Multiple endocrine neoplasia: This condition involves the development of tumors in multiple endocrine glands, such as the thyroid, adrenal glands, and pancreas. While not directly related to Cowden syndrome, multiple endocrine neoplasia can present with similar symptoms [2].
- Tuberous sclerosis: This is a genetic disorder that affects multiple organ systems, including the skin, brain, kidneys, and heart. Like Cowden syndrome, tuberous sclerosis is characterized by the development of hamartomas and an increased risk of certain cancers [3].
- Darier disease: This is a rare genetic disorder that affects the skin, causing it to become thickened and discolored. While not directly related to Cowden syndrome, Darier disease can present with similar symptoms [4].
It's worth noting that these conditions are not exhaustive, and other differential diagnoses may be considered on a case-by-case basis.
References:
[1] Birt-Hogg-Dube syndrome: A rare genetic disorder characterized by multiple hamartomas and an increased risk of certain cancers. (Source: Search result 8)
[2] Multiple endocrine neoplasia: A condition involving the development of tumors in multiple endocrine glands. (Source: Search result 3)
[3] Tuberous sclerosis: A genetic disorder that affects multiple organ systems, including the skin, brain, kidneys, and heart. (Source: Search result 4)
[4] Darier disease: A rare genetic disorder that affects the skin, causing it to become thickened and discolored. (Source: Search result 2)
Additional Differential Diagnoses
Additional Information
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#id
- DOID:0081003
- core#notation
- DOID:0081003
- oboInOwl#hasDbXref
- MIM:616858
- IAO_0000115
- A Cowden syndrome that has_material_basis_in heterozygous mutation in the SEC23B gene on chromosome 20p11.
- rdf-schema#label
- Cowden syndrome 7
- rdf-schema#subClassOf
- http://purl.obolibrary.org/obo/DOID_6457
- relatedICD
- http://example.org/icd10/Q85.82
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_3848
- owl#annotatedSource
- t357625
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.